A carregar...
Suicidality in a Placebo-Controlled Fluoxetine Study of Body Dysmorphic Disorder
OBJECTIVES: SRIs are considered the first-line medication for body dysmorphic disorder (BDD). The relationship between SRI treatment and suicidality in BDD has been only minimally studied, despite high suicidality rates in BDD. METHODS: Sixty-seven adults with DSM-IV BDD participated in a 12-week ra...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2677723/ https://ncbi.nlm.nih.gov/pubmed/19060721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0b013e32831db2e9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|